Recent studies have revealed that ADGRG1+CD8+ T cells, following allogeneic HSCT, function as allo-reactive cytotoxic T cells that are capable of recognizing the patients’ original AML blasts [40]. The gene discussed is CD8A; the disease is acute myeloid leukemia.